The short version of HPLC-UV fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-23. Anything still debated is marked as such rather than presented as settled.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| Molecular weight | 437.9 g/mol | Calculated from the formula |
| Primary target | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian regulation |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water |
| Typical storage | -20 °C, desiccated | Protect from light and moisture |
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
Cossacks of Ryazan are mentioned in 1444 as defenders of Pereslavl-Zalessky against the units of Golden Horde and in a letter of Ivan III of Russia from 1502. After the Golden Horde fell in 1480, the area around the Don River was divided between the Crimean west side and the Nogai east side. On their border since the 14th century the vast steppe of the Don region was populated by those people who were not satisfied with the existing social order, by those who did not recognize the power of the land-owners, by runaway serfs, by those who longed for freedom. In the course of time they turned into a united community and were called "the Cossacks". At first the main occupation of these small armed detachments was hunting and fishing—as well as the constant struggle against the Turks and the Tatars who attacked them. Only later they began to settle and work on the land.
== External links == leukotriene-C4+synthase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) UMich Orientation of Proteins in Membranes families/superfamily-199 - Eicosanoid and Glutathione metabolism protein family (MAPEG)
== Efficiency of bond-skipping == Different 2A peptides have different peptide-bond-skipping efficiencies, with T2A and P2A being the most efficient and F2A the least efficient. Therefore, up to 50% of F2A-linked proteins can in fact be produced as a fusion protein, which might cause some unpredictable outcomes, including a gain of function. One study reported that 2A sites cause the ribosome to fall off approximately 60% of the time, and that, together with ribosome read-through of about 10% for P2A and T2A, this results in reducing expression of the downstream peptide chain by about 70%. However, the level of drop-off detected in this study varied widely depending on the exact construct used, with some constructs showing little evidence of drop-off; furthermore, within a tri-cistronic transcript it reported a higher level of ribosome drop-off after one 2A sequence than after two 2As combined, which is at odds with a linear model of translation.
Chick-fil-A have opened their first full UK restaurant in Lisburn, Northern Ireland in January 2025, followed by a second one in Templepatrick, Northern Ireland in February 2025 under a partnership with Welcome Break, a subsidiary of Applegreen. A third location in Leeds, West Yorkshire opened in October 2025. Another location in Kingston upon Thames, London opened in March 2026.
A more recent application of bone grafting is its use as an antibiotic carrier. Infected bone is poorly perfused, making it difficult to achieve an appropriate antibiotic concentration at the site of infection when intravenous administration is used, especially for antibiotics with large molecules such as vancomycin. In such cases, impacted morcellized bone allografts (IBG), impregnated with local antibiotics can achieve much higher concentrations of antibiotics locally than the minimum inhibitory concentration (MIC).
Sources: en.wikipedia.org
== Related compounds == Later work showed that replacing the chlorine atom with a fluorine atom (2F-Viminol) or with a trifluoromethyl group produced a compound with twice the potency and half the acute toxicity. A later team at Zambon found that one isomer of a pyrrolidone analog is 318 times as potent as morphine in its analgesic activity in animal studies. A number of related compounds were also found to be active, allowing a QSAR model to be constructed.
=== Candice Allbright === Candice Allbright (Alexandra Moen) is Eric's wife, with whom he has two daughters. She and Eric share a profane sense of humor. She later divorces Eric between series 2 and 3. In series 4, Candice and Eric learn that their daughter Lily has been expelled from school for catfishing another student; Candice blames Lily's behavioral issues on Eric's absence as a father. Eric lets Candice and Lily stay at the hotel suite serving as the office of SternTao, his hedge fund with Harper. Candice tells Eric not to "confuse regret with love."
Nayib Armando Bukele Ortez (born 24 July 1981) is a Salvadoran politician who has served as the 43rd president of El Salvador since 2019. In 1999, Bukele established an advertising company and worked at another owned by his father, Armando Bukele Kattán. Both companies advertised election campaigns for the Farabundo Martí National Liberation Front (FMLN) political party. Bukele entered politics in 2011. In 2012, he joined the FMLN and was elected mayor of Nuevo Cuscatlán. Bukele served until his 2015 election as Mayor of San Salvador, where he served until 2018. In 2017, Bukele was ousted from the FMLN. He founded the Nuevas Ideas political party shortly afterward and pursued a presidential campaign in 2019. After the Supreme Electoral Court (TSE) refused to register his party, Bukele ran for president with the Grand Alliance for National Unity (GANA) and won with 53 percent of the vote. In July 2019, Bukele implemented the Territorial Control Plan to reduce El Salvador's 2019 homicide rate of 38 per 100,000 people. Homicides fell by 50 percent during Bukele's first year in office. After 87 people were killed by gangs over one weekend in March 2022, Bukele initiated a nationwide crackdown on gangs, resulting in the arrests of over 85,000 people with alleged gang affiliations by December 2024. El Salvador's homicide rate officially decreased to 1.9 homicides per 100,000 in 2024, one of the lowest in the Americas, although the factual accuracy has been contested.
The leveraged buyout of Electronic Arts is completed, with a consortium led by Saudi Arabia's Public Investment Fund and including Silver Lake and Affinity Partners acquiring the American video game publisher for US$55 billion and taking it private. The transaction is the largest leveraged buyout in history. The Senate confirms Dr. Erica Schwartz as the director of the Centers for Disease Control and Prevention to succeed acting director Dr. Jay Bhattacharya. August 6 A Republican-led US Senate committee votes to hold former Chief Medical Advisor to the President Anthony Fauci in contempt of Congress, escalating efforts to blame him for potential COVID-19 pandemic mistakes. United States Senator Mitch McConnell is discharged from a rehabilitation center after more than seven weeks of recovery following a June hospitalization. He will continue recovering at home while remaining away from the Senate. A judge in New Mexico orders Meta Platforms to pay an additional $567 million in penalties over five years for liability in knowingly harming children's mental health. August 7 A sweeping Russia sanctions bill negotiated by the late Senator Lindsey Graham is passed by the Senate to force Russian President Vladimir Putin to end the Russo-Ukrainian war. US opens test ranges for small companies to receive munitions faster. Former U.S. president Joe Biden's son Hunter says in a BBC interview that Biden's prostate cancer has metastasized into his bones and further. August 8 The Senate confirms Todd Blanche as the United States attorney general to succeed Pam Bondi.
Sources: en.wikipedia.org
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.
It binds to REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian and metabolic gene regulation. This can alter transcription of genes related to lipid and glucose metabolism in experimental models.
No controlled human trials have established that effect. Endurance findings come primarily from rodent studies, and human responses remain unknown.
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.